Wells Fargo & Company Wave Life Sciences Ltd. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding WVE
# of Institutions
147Shares Held
94MCall Options Held
33KPut Options Held
57.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$270 Million1.37% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.67MShares$114 Million0.75% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$99.9 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$91.4 Million35.47% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.36MShares$79.5 Million0.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.29B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...